Giovanni Antico

692 total citations
12 papers, 278 citations indexed

About

Giovanni Antico is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Giovanni Antico has authored 12 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in Giovanni Antico's work include Pancreatic and Hepatic Oncology Research (2 papers), Renal cell carcinoma treatment (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Giovanni Antico is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Renal cell carcinoma treatment (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Giovanni Antico collaborates with scholars based in United States, Italy and Slovenia. Giovanni Antico's co-authors include Charles V. Clevenger, Puthiyaveettil N. Raghunath, J E Tomaszewski, Antonella Sassano, Leonidas C. Platanias, Feng Fang, Stefano Fiore, Jiamao Zheng, Efstratios Katsoulidis and Martin S. Tallman and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Giovanni Antico

11 papers receiving 276 citations

Peers

Giovanni Antico
N Wong Hong Kong
Jian Gu China
N. Gavalas Greece
Liran Zhou United States
Michael W. Potter United States
Giovanni Antico
Citations per year, relative to Giovanni Antico Giovanni Antico (= 1×) peers Olga Aleynikova

Countries citing papers authored by Giovanni Antico

Since Specialization
Citations

This map shows the geographic impact of Giovanni Antico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Antico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Antico more than expected).

Fields of papers citing papers by Giovanni Antico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Antico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Antico. The network helps show where Giovanni Antico may publish in the future.

Co-authorship network of co-authors of Giovanni Antico

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Antico. A scholar is included among the top collaborators of Giovanni Antico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Antico. Giovanni Antico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ayyappan, Sabarish, H. Miles Prince, Cecilia Carpio, et al.. (2024). Dynamics of Complete Responses in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Odronextamab in the ELM-2 Study. Blood. 144(Supplement 1). 4486–4486.
2.
Cole, Ashley L., et al.. (2020). The economic burden of metastatic pancreatic cancer. Pancreatology. 20(7). 1434–1441. 8 indexed citations
3.
Lal, Lincy S., et al.. (2020). Treatment patterns and outcomes in pancreatic cancer: Retrospective claims analysis. Cancer Medicine. 9(10). 3463–3476. 16 indexed citations
4.
Antico, Giovanni, et al.. (2014). Uteroglobin, a Possible Ligand of the Lipoxin Receptor Inhibits Serum Amyloid A-Driven Inflammation. Mediators of Inflammation. 2014. 1–10. 11 indexed citations
5.
Sassano, Antonella, Marco Lo Iacono, Giovanni Antico, et al.. (2009). Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins. Molecular Cancer Therapeutics. 8(3). 615–625. 13 indexed citations
6.
Antico, Giovanni, et al.. (2009). Lipoxin A4and Serum Amyloid a Differentially Modulate Phospholipase D in Human Fibroblast-Like Synoviocytes. European Journal of Inflammation. 7(1). 9–17. 4 indexed citations
7.
Fang, Feng, Giovanni Antico, Jiamao Zheng, & Charles V. Clevenger. (2008). Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter. BMC Biotechnology. 8(1). 11–11. 34 indexed citations
8.
Antico, Giovanni, et al.. (2007). Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells. Oncogene. 26(32). 4668–4678. 69 indexed citations
9.
Sassano, Antonella, Efstratios Katsoulidis, Giovanni Antico, et al.. (2007). Suppressive Effects of Statins on Acute Promyelocytic Leukemia Cells. Cancer Research. 67(9). 4524–4532. 65 indexed citations
10.
Antico, Giovanni, Mark W. Lingen, Antonella Sassano, et al.. (2006). Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectin. Journal of Cellular Physiology. 207(2). 553–561. 23 indexed citations
11.
Fiore, Stefano, et al.. (2005). Lipoxin A4 biology in the human synovium. Role of the ALX signaling pathways in modulation of inflammatory arthritis. Prostaglandins Leukotrienes and Essential Fatty Acids. 73(3-4). 189–196. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026